AIMS: We aimed to evaluate the effectiveness of excimer laser coronary angioplasty (ELCA) to treat in-stent restenosis (ISR) due to peri-stent calcium-related stent underexpansion as assessed by optical coherence tomography (OCT). METHODS AND RESULTS: We studied 81 patients (81 lesions with ISR, stent underexpansion, and peri-stent calcium >90°) who underwent OCT imaging both pre and post percutaneous coronary intervention and compared lesions treated with ELCA (n=23) vs. without ELCA (n=58). ELCA use was associated with more calcium fracture (ELCA: 61%, non-ELCA: 12%, p<0.01), larger final minimum lumen area (ELCA: 4.76 mm2 [3.25, 5.57], non-ELCA: 3.46 mm2 [2.80, 4.13], p<0.01), and a larger previously implanted stent area (ELCA: 6.15 mm2 [4.83, 7.09], non-ELCA: 4.65 mm2 [3.84, 5.40], p<0.01). In the multivariable model, ELCA use was associated with peri-stent calcium fracture (odds ratio 46.5, 95% confidence interval: 6.8, 315.9, p<0.001) that, in turn, was associated with final larger lumen and stent dimensions. Finally, contrast injection during ELCA was associated with multiple calcium fractures and fractures even in thicker calcium. CONCLUSIONS: ELCA is effective for treating ISR with underexpansion by disrupting peri-stent calcium, facilitating better expansion of the previously implanted stent.
AIMS: We aimed to evaluate the effectiveness of excimer laser coronary angioplasty (ELCA) to treat in-stent restenosis (ISR) due to peri-stent calcium-related stent underexpansion as assessed by optical coherence tomography (OCT). METHODS AND RESULTS: We studied 81 patients (81 lesions with ISR, stent underexpansion, and peri-stent calcium >90°) who underwent OCT imaging both pre and post percutaneous coronary intervention and compared lesions treated with ELCA (n=23) vs. without ELCA (n=58). ELCA use was associated with more calciumfracture (ELCA: 61%, non-ELCA: 12%, p<0.01), larger final minimum lumen area (ELCA: 4.76 mm2 [3.25, 5.57], non-ELCA: 3.46 mm2 [2.80, 4.13], p<0.01), and a larger previously implanted stent area (ELCA: 6.15 mm2 [4.83, 7.09], non-ELCA: 4.65 mm2 [3.84, 5.40], p<0.01). In the multivariable model, ELCA use was associated with peri-stent calciumfracture (odds ratio 46.5, 95% confidence interval: 6.8, 315.9, p<0.001) that, in turn, was associated with final larger lumen and stent dimensions. Finally, contrast injection during ELCA was associated with multiple calciumfractures and fractures even in thicker calcium. CONCLUSIONS: ELCA is effective for treating ISR with underexpansion by disrupting peri-stent calcium, facilitating better expansion of the previously implanted stent.
Authors: Keyvan Karimi Galougahi; Evan Shlofmitz; Allen Jeremias; Shawnbir Gogia; Ajay J Kirtane; Jonathan M Hill; Dimitri Karmpaliotis; Gary S Mintz; Akiko Maehara; Gregg W Stone; Richard A Shlofmitz; Ziad A Ali Journal: Curr Cardiol Rep Date: 2021-03-05 Impact factor: 2.931
Authors: Wojciech Wańha; Mariusz Tomaniak; Piotr Wańczura; Jacek Bil; Rafał Januszek; Rafał Wolny; Maksymilian P Opolski; Łukasz Kuźma; Adam Janas; Tomasz Figatowski; Paweł Gąsior; Marek Milewski; Magda Roleder-Dylewska; Łukasz Lewicki; Jan Kulczycki; Adrian Włodarczak; Brunon Tomasiewicz; Sylwia Iwańczyk; Jerzy Sacha; Łukasz Koltowski; Miłosz Dziarmaga; Miłosz Jaguszewski; Paweł Kralisz; Bartosz Olajossy; Grzegorz Sobieszek; Krzysztof Dyrbuś; Mariusz Łebek; Grzegorz Smolka; Krzysztof Reczuch; Robert J Gil; Sławomir Dobrzycki; Piotr Kwiatkowski; Marcin Rogala; Mariusz Gąsior; Andrzej Ochała; Janusz Kochman; Adam Witkowski; Maciej Lesiak; Fabrizio D'Ascenzo; Stanisław Bartuś; Wojciech Wojakowski Journal: J Clin Med Date: 2022-03-23 Impact factor: 4.241